vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and Phillips Edison & Company, Inc. (PECO). Click either name above to swap in a different company.

Phillips Edison & Company, Inc. is the larger business by last-quarter revenue ($190.7M vs $37.2M, roughly 5.1× Organogenesis Holdings Inc.). On growth, Phillips Edison & Company, Inc. posted the faster year-over-year revenue change (7.0% vs -57.1%). Over the past eight quarters, Phillips Edison & Company, Inc.'s revenue compounded faster (8.7% CAGR vs -46.5%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Consolidated Edison, Inc., commonly known as Con Edison or ConEd, is an energy company based in New York City. It is one of the largest investor-owned energy companies in the United States, with approximately $15.26 billion in annual revenues as of 2024, and over $70 billion in assets. The company provides a wide range of energy-related products and services to its customers through its subsidiaries:Consolidated Edison Company of New York, Inc. (CECONY), a regulated utility providing electric...

ORGO vs PECO — Head-to-Head

Bigger by revenue
PECO
PECO
5.1× larger
PECO
$190.7M
$37.2M
ORGO
Growing faster (revenue YoY)
PECO
PECO
+64.0% gap
PECO
7.0%
-57.1%
ORGO
Faster 2-yr revenue CAGR
PECO
PECO
Annualised
PECO
8.7%
-46.5%
ORGO

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
ORGO
ORGO
PECO
PECO
Revenue
$37.2M
$190.7M
Net Profit
$33.2M
Gross Margin
30.8%
Operating Margin
-185.1%
30.5%
Net Margin
17.4%
Revenue YoY
-57.1%
7.0%
Net Profit YoY
15.1%
EPS (diluted)
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
PECO
PECO
Q1 26
$37.2M
$190.7M
Q4 25
$225.6M
$187.9M
Q3 25
$150.9M
$182.7M
Q2 25
$101.0M
$177.8M
Q1 25
$86.7M
$178.3M
Q4 24
$126.7M
$173.0M
Q3 24
$115.2M
$165.5M
Q2 24
$130.2M
$161.5M
Net Profit
ORGO
ORGO
PECO
PECO
Q1 26
$33.2M
Q4 25
$43.7M
$47.5M
Q3 25
$21.6M
$24.7M
Q2 25
$-9.4M
$12.8M
Q1 25
$-18.8M
$26.3M
Q4 24
$7.7M
$18.1M
Q3 24
$12.3M
$11.6M
Q2 24
$-17.0M
$15.3M
Gross Margin
ORGO
ORGO
PECO
PECO
Q1 26
30.8%
Q4 25
Q3 25
Q2 25
Q1 25
72.6%
Q4 24
75.5%
Q3 24
76.7%
Q2 24
77.6%
Operating Margin
ORGO
ORGO
PECO
PECO
Q1 26
-185.1%
30.5%
Q4 25
28.1%
Q3 25
13.7%
Q2 25
-12.5%
Q1 25
-30.9%
Q4 24
8.1%
Q3 24
5.4%
Q2 24
-10.7%
Net Margin
ORGO
ORGO
PECO
PECO
Q1 26
17.4%
Q4 25
19.4%
25.3%
Q3 25
14.3%
13.5%
Q2 25
-9.3%
7.2%
Q1 25
-21.7%
14.8%
Q4 24
6.1%
10.5%
Q3 24
10.7%
7.0%
Q2 24
-13.1%
9.5%
EPS (diluted)
ORGO
ORGO
PECO
PECO
Q1 26
$0.24
Q4 25
$0.31
$0.38
Q3 25
$0.11
$0.20
Q2 25
$-0.10
$0.10
Q1 25
$-0.17
$0.21
Q4 24
$0.05
$0.16
Q3 24
$0.09
$0.09
Q2 24
$-0.13
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
PECO
PECO
Cash + ST InvestmentsLiquidity on hand
$91.4M
$3.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$2.3B
Total Assets
$520.0M
$5.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
PECO
PECO
Q1 26
$91.4M
$3.1M
Q4 25
$93.7M
$3.5M
Q3 25
$63.7M
$4.1M
Q2 25
$73.1M
$5.6M
Q1 25
$110.0M
$5.5M
Q4 24
$135.6M
$4.9M
Q3 24
$94.3M
$6.4M
Q2 24
$89.9M
$7.1M
Total Debt
ORGO
ORGO
PECO
PECO
Q1 26
Q4 25
$2.4B
Q3 25
$2.4B
Q2 25
$2.4B
Q1 25
$2.3B
Q4 24
$2.1B
Q3 24
$62.3M
$2.1B
Q2 24
$63.8M
$2.0B
Stockholders' Equity
ORGO
ORGO
PECO
PECO
Q1 26
$2.3B
Q4 25
$300.1M
$2.3B
Q3 25
$255.1M
$2.3B
Q2 25
$233.2M
$2.3B
Q1 25
$242.9M
$2.3B
Q4 24
$262.9M
$2.3B
Q3 24
$278.5M
$2.2B
Q2 24
$263.5M
$2.3B
Total Assets
ORGO
ORGO
PECO
PECO
Q1 26
$520.0M
$5.4B
Q4 25
$598.7M
$5.3B
Q3 25
$509.8M
$5.3B
Q2 25
$461.1M
$5.3B
Q1 25
$467.4M
$5.2B
Q4 24
$497.9M
$5.0B
Q3 24
$446.3M
$5.0B
Q2 24
$443.2M
$4.9B
Debt / Equity
ORGO
ORGO
PECO
PECO
Q1 26
Q4 25
1.04×
Q3 25
1.05×
Q2 25
1.04×
Q1 25
0.99×
Q4 24
0.91×
Q3 24
0.22×
0.94×
Q2 24
0.24×
0.90×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
PECO
PECO
Operating Cash FlowLast quarter
$55.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
12.6%
Cash ConversionOCF / Net Profit
1.67×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
PECO
PECO
Q1 26
$55.6M
Q4 25
$39.4M
$348.1M
Q3 25
$3.1M
$95.4M
Q2 25
$-32.9M
$96.1M
Q1 25
$-19.9M
$60.5M
Q4 24
$10.9M
$334.7M
Q3 24
$8.7M
$109.1M
Q2 24
$4.7M
$78.5M
Free Cash Flow
ORGO
ORGO
PECO
PECO
Q1 26
Q4 25
$34.8M
Q3 25
$844.0K
Q2 25
$-36.5M
Q1 25
$-23.6M
Q4 24
$7.6M
Q3 24
$6.1M
Q2 24
$2.9M
FCF Margin
ORGO
ORGO
PECO
PECO
Q1 26
Q4 25
15.4%
Q3 25
0.6%
Q2 25
-36.1%
Q1 25
-27.2%
Q4 24
6.0%
Q3 24
5.3%
Q2 24
2.2%
Capex Intensity
ORGO
ORGO
PECO
PECO
Q1 26
12.6%
Q4 25
2.1%
Q3 25
1.5%
Q2 25
3.6%
Q1 25
4.2%
Q4 24
2.7%
Q3 24
2.2%
Q2 24
1.4%
Cash Conversion
ORGO
ORGO
PECO
PECO
Q1 26
1.67×
Q4 25
0.90×
7.33×
Q3 25
0.14×
3.87×
Q2 25
7.52×
Q1 25
2.30×
Q4 24
1.43×
18.45×
Q3 24
0.71×
9.40×
Q2 24
5.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORGO
ORGO

Segment breakdown not available.

PECO
PECO

Rental income$186.3M98%
Fees and management income$3.4M2%

Related Comparisons